Type 2 Inflammatory Responses in Autoimmune Demyelination of the Central Nervous System: Recent Advances
Open Access
- 8 May 2019
- journal article
- review article
- Published by Wiley in Journal of Immunology Research
- Vol. 2019, 1-10
Abstract
Type 2 immunity has long been confined to a restricted spectrum of responses, mostly including allergic reactions to innocuous environmental triggers. However, growing evidence suggests that cells and mediators typically associated with type 2 inflammation are involved in several physiopathological conditions, such as defense against toxic substances, anticancer immunity, and autoimmune diseases. In neuromyelitis optica, an autoimmune demyelinating disorder of the spinal cord and optic nerve, eosinophils extensively infiltrate lesions in the central nervous system (CNS) and promote tissue pathology in experimental models of this disease. Next-generation sequencing of CD4+ T cells isolated from a specific subtype of multiple sclerosis plaque has uncovered an unexpectedly Th2 profile of these cells. Even mast cells and other allergic mediators have been implicated in the modulation and/or effector mechanisms of autoimmune reactions against the CNS. In this review article, the most recent developments showing the involvement of type 2 inflammatory components in CNS autoimmunity are summarised and possible lines of further investigation are discussed.Keywords
This publication has 93 references indexed in Scilit:
- Aquaporin 4‐specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporterAnnals of Neurology, 2012
- Cre-Mediated Cell Ablation Contests Mast Cell Contribution in Models of Antibody- and T Cell-Mediated AutoimmunityImmunity, 2011
- Endothelial histamine H1receptor signaling reduces blood–brain barrier permeability and susceptibility to autoimmune encephalomyelitisProceedings of the National Academy of Sciences, 2010
- Basophils and the T helper 2 environment can promote the development of lupus nephritisNature Medicine, 2010
- T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitisNature Medicine, 2010
- Autoimmune T cell responses in the central nervous systemNature Reviews Immunology, 2009
- Multiple sclerosisThe Lancet, 2008
- The development of allergic inflammationNature, 2008
- Central histamine H3receptor signaling negatively regulates susceptibility to autoimmune inflammatory disease of the CNSProceedings of the National Academy of Sciences, 2007
- TH-17 cells in the circle of immunity and autoimmunityNature Immunology, 2007